688 related articles for article (PubMed ID: 27486822)
21. Prognostic impact of tumor perfusion in MR-imaging studies in Ewing tumors.
Dunst J; Ahrens S; Paulussen M; Burdach S; Jürgens H
Strahlenther Onkol; 2001 Mar; 177(3):153-9. PubMed ID: 11285773
[TBL] [Abstract][Full Text] [Related]
22. Survival outcomes in pediatric patients with metastatic Ewing sarcoma who achieve a rapid complete response of pulmonary metastases.
Reiter AJ; Huang L; Craig BT; Davidoff AM; Talbot LJ; Coggins J; Smith J; Aldrink JH; Bergus KC; MacArthur TA; Polites SF; Boehmer C; Brungardt J; Malek MM; Rinehardt HN; Kastenberg ZJ; Arkin CM; Gourmel A; Piche N; Wallace M; Liang J; Lovvorn HN; Petroze RT; Gillies G; Marquart JP; Becktell K; Le HD; Favela J; Rich BS; Glick RD; Seemann NM; Davidson J; Wilson CA; Roach J; Brown EG; Doyle KE; Coakley BA; Emengo P; Merola P; Grant CN; Tirumani A; Tracy ET; Moya-Mendez ME; Dasgupta R; Lautz TB;
Pediatr Blood Cancer; 2024 Jul; 71(7):e31026. PubMed ID: 38679864
[TBL] [Abstract][Full Text] [Related]
23. Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology.
Carrie C; Mascard E; Gomez F; Habrand JL; Alapetite C; Oberlin O; Moncho V; Hoffstetter S
Med Pediatr Oncol; 1999 Nov; 33(5):444-9. PubMed ID: 10531567
[TBL] [Abstract][Full Text] [Related]
24. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1.
Becker RG; Gregianin LJ; Galia CR; Jesus-Garcia Filho R; Toller EA; Badell G; Nakagawa SA; David A; Baptista AM; Yonamime ES; Serafini OA; Penna V; Santos JFC; Brunetto AL;
BMC Cancer; 2017 Jun; 17(1):420. PubMed ID: 28619077
[TBL] [Abstract][Full Text] [Related]
25. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
[TBL] [Abstract][Full Text] [Related]
26. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease.
Ahmed SK; Robinson SI; Okuno SH; Rose PS; Issa Laack NN
Am J Clin Oncol; 2014 Oct; 37(5):423-9. PubMed ID: 23388557
[TBL] [Abstract][Full Text] [Related]
27. Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapy.
Kreyer J; Ranft A; Timmermann B; Juergens H; Jung S; Wiebe K; Boelling T; Schuck A; Vieth V; Streitbuerger A; Hardes J; Heinemann M; Dirksen U
Pediatr Blood Cancer; 2018 Dec; 65(12):e27384. PubMed ID: 30084137
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and therapeutic factors influencing the clinical outcome of metastatic Ewing sarcoma family of tumors: A retrospective report from the Japan Ewing Sarcoma Study Group.
Umeda K; Miyamura T; Yamada K; Sano H; Hosono A; Sumi M; Okita H; Kamio T; Maeda N; Fujisaki H; Jyoko R; Watanabe A; Hosoya Y; Hasegawa D; Takenaka S; Nakagawa S; Chin M; Ozaki T;
Pediatr Blood Cancer; 2021 Mar; 68(3):e28844. PubMed ID: 33340261
[TBL] [Abstract][Full Text] [Related]
29. Radiation Treatment for Ewing Sarcoma Family of Tumors in Adult Patients: A Single Institution's Experience Over 40 Years.
Kharod SM; Spiguel AR; Lagmay JP; Jones C; Morris CG; Gibbs CP; Zlotecki RA
Am J Clin Oncol; 2019 May; 42(5):421-425. PubMed ID: 30883389
[TBL] [Abstract][Full Text] [Related]
30. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
[TBL] [Abstract][Full Text] [Related]
32. Management and Outcome of Ewing Sarcoma of the Head and Neck.
Grevener K; Haveman LM; Ranft A; van den Berg H; Jung S; Ladenstein R; Klco-Brosius S; Juergens H; Merks JH; Dirksen U
Pediatr Blood Cancer; 2016 Apr; 63(4):604-10. PubMed ID: 26702872
[TBL] [Abstract][Full Text] [Related]
33. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
[TBL] [Abstract][Full Text] [Related]
34. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W
Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763
[TBL] [Abstract][Full Text] [Related]
35. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
Burdach S; Jürgens H; Peters C; Nürnberger W; Mauz-Körholz C; Körholz D; Paulussen M; Pape H; Dilloo D; Koscielniak E
J Clin Oncol; 1993 Aug; 11(8):1482-8. PubMed ID: 8101562
[TBL] [Abstract][Full Text] [Related]
36. Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
van Maldegem AM; Benson C; Rutkowski P; Blay JY; van den Berg H; Placzke J; Rasper M; Judson I; Juergens H; Dirksen U; Gelderblom H
Pediatr Blood Cancer; 2015 Jan; 62(1):40-4. PubMed ID: 25251256
[TBL] [Abstract][Full Text] [Related]
37. Outcomes and prognostic factors for Ewing-family tumors of the extremities.
Biswas B; Rastogi S; Khan SA; Mohanti BK; Sharma DN; Sharma MC; Mridha AR; Bakhshi S
J Bone Joint Surg Am; 2014 May; 96(10):841-9. PubMed ID: 24875025
[TBL] [Abstract][Full Text] [Related]
38. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma.
Boulad F; Kernan NA; LaQuaglia MP; Heller G; Lindsley KL; Rosenfield NS; Abramson SJ; Gerald WL; Small TN; Gillio AP; Gulati SC; O'Reilly RJ; Ghavimi F
J Clin Oncol; 1998 May; 16(5):1697-706. PubMed ID: 9586881
[TBL] [Abstract][Full Text] [Related]
39. [Combined therapy for children and adolescents with Ewing tumors (a 25-year experience)].
Yukhta TV; Punanov YA; Kazantsev IV; Malinin AP; Safonova SA; Gafton GI; Gevorgyan AG; Morozova EV; Zubarovskaya LS; Fanasiev BV
Vopr Onkol; 2015; 61(2):233-8. PubMed ID: 26087604
[TBL] [Abstract][Full Text] [Related]
40. Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing Sarcoma.
Scobioala S; Ranft A; Wolters H; Jabar S; Paulussen M; Timmermann B; Juergens H; Hassenpflug W; Klingebiel T; Elsayad K; Eich HT; Dirksen U
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):584-592. PubMed ID: 30244879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
